Hydroxyzine is NOT Appropriate for Treating Restless Legs Syndrome
Do not use hydroxyzine for RLS treatment—it is not recommended by current guidelines and may actually worsen symptoms as an antihistamine.
Why Hydroxyzine Should Be Avoided
The most recent 2025 American Academy of Sleep Medicine (AASM) clinical practice guideline for RLS treatment makes no mention of hydroxyzine as a treatment option 1. This is a critical omission because the guideline comprehensively addresses both recommended and specifically discouraged medications.
More importantly, antihistamines are known to exacerbate RLS symptoms. The research literature explicitly identifies antihistamine administration as a factor that worsens RLS and should be addressed as part of initial management 2. Hydroxyzine is a first-generation antihistamine with significant anticholinergic and sedating properties 3, placing it in the category of medications that can aggravate rather than improve RLS.
What You Should Use Instead
Based on the 2025 AASM guidelines, the evidence-based treatment hierarchy for RLS is:
First-Line Treatments (Strong Recommendations):
- Gabapentin (strong recommendation, moderate certainty) 1
- Pregabalin (strong recommendation, moderate certainty) 1
- IV ferric carboxymaltose in patients with appropriate iron status (strong recommendation, moderate certainty) 1
Second-Line Options (Conditional Recommendations):
- Ferrous sulfate for oral iron supplementation (conditional recommendation, moderate certainty) 1
- Extended-release oxycodone and other opioids (conditional recommendation, moderate certainty) 1
- Dipyridamole (conditional recommendation, low certainty) 1
Medications to Use Cautiously or Avoid:
The AASM suggests against standard use of dopamine agonists (pramipexole, ropinirole, rotigotine) due to augmentation risk with long-term use, though they may be considered for short-term symptom reduction 1.
Clinical Pitfalls
Common mistake: Prescribing sedating antihistamines like hydroxyzine for the sleep disturbance associated with RLS. While hydroxyzine has demonstrated mixed efficacy for insomnia in general 4, using it in RLS patients is counterproductive because:
- It may worsen the underlying RLS symptoms
- The sedation does not address the sensory-motor symptoms driving the sleep disruption
- It can cause additional adverse effects (dry mouth, QT prolongation risk, CNS depression) 3
Better approach: Address the RLS itself with guideline-concordant therapy. Once RLS symptoms are controlled, the associated sleep disturbance typically improves without need for additional hypnotics.
Initial Management Algorithm
Identify and remove secondary causes: Check iron studies (ferritin, transferrin saturation), review medication list for RLS-worsening agents (antidepressants, antihistamines), screen for sleep apnea 2, 5
For intermittent RLS: Behavioral measures and on-demand therapy 5
For chronic persistent RLS: Start with α2δ calcium channel ligands (gabapentin or pregabalin) as first-line 1, 5
If refractory: Consider polytherapy or opioid monotherapy 5
The evidence is unequivocal: hydroxyzine has no role in RLS treatment and should be actively avoided due to its antihistaminergic properties that can exacerbate symptoms.